Intuitive Surgical’s Ion Robotic System Gains Regulatory Approval in China
Intuitive Surgical (NASDAQ: ISRG), a leading medical robotics firm based in the US, has announced...
Henlius Biotech Posts 67.8% YOY Revenue Growth and First Annual Profit in 2023 Financials
Shanghai Henlius Biotech Inc., (HKG: 2696) has released its financial results for 2023, reporting revenues...
Bayer Eliminates C-Level Roles in Restructuring Efforts to Boost Profitability
Germany’s Bayer (ETR: BAYN) has taken significant steps in its restructuring efforts by eliminating 8...
Baidu Health Partners with Yibang to Enhance Operations for Brick-and-Mortar Pharmacies
Baidu Health has entered into a strategic partnership with Shanghai Yibang Medicine Information Technology Co.,...
Edan Instruments Partners with Global Health Labs to Develop AI-Enhanced Handheld Ultrasound
Shenzhen-based Edan Instruments Inc. has forged a strategic partnership with Global Health Labs Inc. to...
FDA Grants Accelerated Approval for Takeda’s Iclusig in Newly Diagnosed Ph+ ALL
The U.S. Food and Drug Administration (FDA) has granted accelerated indication extension approval to Japan’s...
China Unveils Action Plan to Boost Foreign Investment and Open Economy Further
The State Council of China has unveiled an ambitious “Action Plan to Promote the High-Level...
Simcere Pharmaceutical Reports 4.5% Revenue Growth in 2023 Amid Shifts in Profitability
Simcere Pharmaceutical Group (HKG: 2096), based in China, has released its 2023 financial performance report,...
Sinopharm and Fresenius Kabi Expand Partnership to Enhance Drug Distribution and Healthcare Services
China’s state-owned Sinopharm Group Co., Ltd. (HKG: 1099) has announced a new partnership with Germany’s...
Bayer and Thermo Fisher Partner to Develop Rapid Companion Diagnostics for Precision Oncology
Germany’s Bayer (NYSE: BAYE) has entered into a strategic partnership with U.S. life sciences leader...
iRegene’s NouvSight001 Gains Orphan Drug Designation for Retinitis Pigmentosa Treatment
Wuhan-based cell therapy innovator iRegene has secured Orphan Drug Designation (ODD) from the U.S. FDA...
BMS Reports Positive Phase III Results for Opdivo and Yervoy in Advanced HCC
Bristol Myers Squibb (BMS; NYSE: BMY) announced this week that its Phase III study evaluating...
China Resources Guangdong Pharmaceutical Partners with BD to Enhance Drug and Device Distribution in GBA
China Resources Guangdong Pharmaceutical Co., Ltd has entered into a strategic partnership with U.S.-based Becton,...
CAIR Launches CARES Copilot 1.0: A Revolutionary AI Chatbot for Medical Diagnosis and Treatment
The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences...
VIVA Biotech Secures Licensing Deal with Lonza for Advanced Bispecific Antibody Technology
VIVA Biotech Holdings (HKG: 1873), a China-based Contract Research Organization (CRO), has entered into a...
Antengene’s ATG-022 Advances to Dose Expansion Phase in Phase II CLINCH Study for Solid Tumors
Antengene Corporation Ltd (HKG: 6996), a leading biopharmaceutical company based in China, has announced that...
CSPC Pharmaceutical Secures NMPA Approval for Clinical Study of SYS6023 in Advanced Solid Tumors
CSPC Pharmaceutical Group Ltd (HKG: 1093), a prominent China-based biopharmaceutical company, has received approval from...
3SBio Reports 13.8% Revenue Growth in 2023, Driven by Strong Sales of Core Biologics
3SBio Inc. (HKG: 1530), a leading China-based biopharmaceutical company, has reported its 2023 financial results,...
Innovent Biologics Reports 36.2% Revenue Growth in 2023, Highlights Robust Product Sales
Innovent Biologics Inc. (HKG: 1801), a China-based biotechnology firm, has released its 2023 financial report,...
Jiangsu Hengrui Receives NMPA Approval for Phase Ib/II Study of HRS2398 in Advanced Solid Tumors
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...